TNYA (Tenaya Therapeutics) Institutional Ownership: 23.97% (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TNYA Tenaya Therapeutics Inc TNYA
30 GF Score
Price $0.67
! 4 Warning Signs
View Full Analysis

What is Tenaya Therapeutics Institutional Ownership?

Tenaya Therapeutics TNYA -2.95% 30 Institutional Ownership is 23.97% as of Sep. 16, 2026. GuruFocus rates TNYA with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tenaya Therapeutics's institutional ownership is 23.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tenaya Therapeutics's Insider Ownership is 0.66%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tenaya Therapeutics's Float Percentage Of Total Shares Outstanding is 77.64%.

Tenaya Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Tenaya Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenaya Therapeutics Institutional Ownership Chart

Tenaya Therapeutics Historical Data

The historical data trend for Tenaya Therapeutics can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 5.07 6.23 6.23 6.30 6.35 6.48 6.52 5.95 8.15 8.17
TNYA
30GF Score
Tenaya Therapeutics Inc TNYA
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenaya Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 23.97% mean?
Tenaya Therapeutics (TNYA) has a Institutional Ownership of 23.97% as of Sep. 16, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Tenaya Therapeutics and its competitors.
Is Tenaya Therapeutics' Institutional Ownership too high?
Tenaya Therapeutics' current Institutional Ownership is 23.97%. Overall, Tenaya Therapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Tenaya Therapeutics' Institutional Ownership compare to OKUR and INDP?
Tenaya Therapeutics' Institutional Ownership of 23.97% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Tenaya Therapeutics and its competitors. Tenaya Therapeutics's current Institutional Ownership is 23.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenaya Therapeutics stock overvalued right now?
Tenaya Therapeutics (TNYA) has a current Institutional Ownership of 23.97%. The current Institutional Ownership is 23.97%. Tenaya Therapeutics' overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Tenaya Therapeutics (TNYA), the current Institutional Ownership is 23.97% as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tenaya Therapeutics Business Description

Address 171 Oyster Point Boulevard, Suite 500, 5th Floor, South San Francisco, CA, USA, 94080
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
30GF Score

Get the complete analysis for TNYA

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price